STRO
Price
$16.86
Change
-$0.97 (-5.44%)
Updated
Sep 11 closing price
Capitalization
279.72M
60 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$10.62
Change
+$0.04 (+0.38%)
Updated
Sep 11 closing price
Capitalization
1.8B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

STRO vs VIR

STRO vs VIR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
STRO vs. VIR commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STRO is a Hold and VIR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.8B) has a higher market cap than STRO($280M). VIR YTD gains are higher at: 76.119 vs. STRO (45.722). STRO has higher annual earnings (EBITDA): -133.09M vs. VIR (-268.68M). VIR has more cash in the bank: 533M vs. STRO (164M). STRO has less debt than VIR: STRO (10.8M) vs VIR (93.3M). VIR has higher revenues than STRO: VIR (303M) vs STRO (45.7M).
STROVIRSTRO / VIR
Capitalization280M1.8B16%
EBITDA-133.09M-268.68M50%
Gain YTD45.72276.11960%
P/E RatioN/AN/A-
Revenue45.7M303M15%
Total Cash164M533M31%
Total Debt10.8M93.3M12%
FUNDAMENTALS RATINGS
STRO vs VIR: Fundamental Ratings
STRO
VIR
OUTLOOK RATING
1..100
5188
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6437
P/E GROWTH RATING
1..100
10023
SEASONALITY SCORE
1..100
250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STRO's Valuation (18) in the Pharmaceuticals Major industry is somewhat better than the same rating for VIR (57) in the null industry. This means that STRO’s stock grew somewhat faster than VIR’s over the last 12 months.

STRO's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VIR (100) in the null industry. This means that STRO’s stock grew similarly to VIR’s over the last 12 months.

VIR's SMR Rating (96) in the null industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that VIR’s stock grew similarly to STRO’s over the last 12 months.

VIR's Price Growth Rating (37) in the null industry is in the same range as STRO (64) in the Pharmaceuticals Major industry. This means that VIR’s stock grew similarly to STRO’s over the last 12 months.

VIR's P/E Growth Rating (23) in the null industry is significantly better than the same rating for STRO (100) in the Pharmaceuticals Major industry. This means that VIR’s stock grew significantly faster than STRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STROVIR
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (STRO: $16.86 vs. VIR: $10.62)
Brand notoriety: STRO and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STRO: 300% vs. VIR: 96%
Market capitalization -- STRO: $279.72M vs. VIR: $1.8B
STRO [@Biotechnology] is valued at $279.72M. VIR’s [@Biotechnology] market capitalization is $1.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STRO’s FA Score shows that 1 FA rating(s) are green while VIR’s FA Score has 1 green FA rating(s).

  • STRO’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than STRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STRO’s TA Score shows that 3 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • STRO’s TA Score: 3 bullish, 4 bearish.
  • VIR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VIR is a better buy in the short-term than STRO.

Price Growth

STRO (@Biotechnology) experienced а -15.99% price change this week, while VIR (@Biotechnology) price change was -6.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

STRO is expected to report earnings on Nov 11, 2026.

VIR is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
STRO
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JENSX44.13N/A
N/A
Jensen Quality Growth J
IMLPX12.61N/A
N/A
MainGate MLP I
PRJIX56.53N/A
N/A
T. Rowe Price New Horizons I
TLCIX22.56N/A
N/A
Touchstone Large Cap Institutional
BFSIX27.12N/A
N/A
BFS Equity Institutional

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with EDIT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-5.44%
EDIT - STRO
35%
Loosely correlated
+1.89%
AXON - STRO
35%
Loosely correlated
+0.10%
VIR - STRO
35%
Loosely correlated
+0.38%
CADL - STRO
35%
Loosely correlated
-6.93%
ELDN - STRO
35%
Loosely correlated
N/A
More